| Study of DAXDILIMAB for the Treatment of Moderate-to-Severe Alopecia Areata (NCT05368103) | Amgen | 2022-04-27 |
| Evaluate the Efficacy and Safety of SHR0302 in Adult Patients With Severe Alopecia Areata (NCT05470413) | Reistone Biopharma Company Limited | 2022-04-18 |
| Extension Study to Evaluate Safety and Efficacy of Jaktinib in Adults With Alopecia Areata (NCT05255237) | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 2022-03-25 |
| Needle-free Delivery of Intralesional Triamcinolone for Pediatric Alopecia Areata (NCT05278858) | University Hospitals Cleveland Medical Center | 2022-03-24 |
| A Study to Evaluate the Safety of MAX-40070 in Healthy Subjects (NCT05196711) | Maxinovel Pty., Ltd. | 2022-02-28 |
| A Study to Evaluate the Efficacy and Safety of Rosnilimab (ANB030) in Treatment of Subjects With Moderate-to-Severe Alopecia Areata (NCT05205070) | AnaptysBio, Inc. | 2021-12-22 |
| Intralesional Vitamin D in Alopecia Areata (NCT04660786) | Alexandria University | 2021-11-01 |
| European Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata (NCT05041803) | Sun Pharmaceutical Industries, Inc. | 2021-10-19 |
| The Epidemiology, Management and Comorbidities in Alopecia Areata in Czech Republic (NCT05098600) | Faculty Hospital Kralovske Vinohrady | 2021-10-15 |
| Study to Evaluate the Safety and Efficacy of Jaktinib in Adults With Alopecia Areata (NCT05051761) | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 2021-09-04 |
| A Novel Formulation of Sildenafil-loaded Nanocarriers for Treatment of Alopecia Areata (NCT06527729) | Assiut University | 2021-07-01 |
| Study to Evaluate the Efficacy and Safety of CTP-543 in Adults With Moderate to Severe Alopecia Areata (THRIVE-AA2) (NCT04797650) | Concert Pharmaceuticals | 2021-06-10 |
| Fecal Transplant for Alopecia Areata (NCT04833179) | Tel-Aviv Sourasky Medical Center | 2021-05-01 |
| Sodium Valproate-loaded Nanospanlastics in Patchy Alopecia Areata in Comparison to Topical Steroids (NCT05017454) | Kasr El Aini Hospital | 2021-05-01 |
| Efficacy of Jessener Solution Versus Intralesional Steroid in Treatment of Alopecia Areata (NCT04964349) | Al-Azhar University | 2021-04-21 |
| Follicular Revival in Treatment-resistant Alopecia Areata: Evaluating Use of Micro-needling (NCT04338295) | Yale University | 2021-04-09 |
| Excimer Light and Topical Steroid in Treatment of Alopecia Areata (NCT04793945) | Assiut University | 2021-04-01 |
| A Study of JNJ-64304500 in Participants With Alopecia Areata (NCT04740970) | Janssen Research & Development, LLC | 2021-03-24 |
| Clinical Trial to Evaluate Effectiveness of a Probiotic Preparation Administered to Patients With Alopecia Areata (NCT05599607) | Bioithas SL | 2021-03-08 |
| A Study to Evaluate the Durability of Response of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata (NCT04784533) | Concert Pharmaceuticals | 2021-02-26 |
| Study to Evaluate the Efficacy and Safety of CTP-543 in Adults With Moderate to Severe Alopecia Areata (THRIVE-AA1) (NCT04518995) | Concert Pharmaceuticals | 2020-11-23 |
| Tofacitinib for Immune Skin Conditions in Down Syndrome (NCT04246372) | University of Colorado, Denver | 2020-10-21 |
| The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata (NCT04239521) | Momentum Data | 2020-10-01 |
| PLACEBO-CONTROLLED SAFETY STUDY OF RITLECITINIB (PF-06651600) IN ADULTS WITH ALOPECIA AREATA (NCT04517864) | Pfizer | 2020-09-15 |
| Safety and Efficacy of Oral Etrasimod in Adult Participants With Moderate-to-Severe Alopecia Areata (NCT04556734) | Pfizer | 2020-07-29 |
| A Phase II Study in Patients With Alopecia Areata (NCT04346316) | Reistone Biopharma Company Limited | 2020-05-13 |
| Topical Crisaborole in Patients with Alopecia Areata (NCT04299503) | Tufts Medical Center | 2020-03-06 |
| Comparative Study Efficacy and Safety of of Activated Versus Non-Activated PRP (NCT05251831) | Al-Azhar University | 2020-02-01 |
| Analysis of Inflammation in the Vitiligo and Other Inflammatory Skin Diseases: Psoriasis, Atopic Dermatitis and Alopecia Areata (NCT03976622) | University Hospital, Bordeaux | 2020-01-14 |
| Modified SALT Score for Alopecia Areata (NCT04412148) | Kasr El Aini Hospital | 2020-01-01 |
| Clinical Trial to Evaluate the Efficacy of Fecal Microbiota Transplantation in Patients With Alopecia Areata (NCT04238091) | Lindsey Bordone | 2019-12-19 |
| Study to Evaluate the Safety and Efficacy ofJaktinib Hydrochloride Tablets in Severe Alopecia Areata (NCT04034134) | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 2019-11-18 |
| Transepidermal Delivery of Triamcinolone Acetonide or Platelet Rich Plasma Using Either Fractional Carbon Dioxide Laser or Microneedling in Treatment of Alopecia Areata (NCT04147845) | Alexandria University | 2019-10-30 |
| Comparative Study for Treatment of Alopecia Areata Using Carboxytherapy and Intralesional Steroids (NCT04228029) | Kasr El Aini Hospital | 2019-08-20 |
| Efficacy of Fractional CO2 Laser as a Mono- or Adjuvant Therapy for Alopecia Areata (NCT04003376) | Assiut University | 2019-07-26 |
| Long-Term PF-06651600 for the Treatment of Alopecia Areata (NCT04006457) | Pfizer | 2019-07-18 |
| A Study of Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopecia Areata (NCT03899259) | Eli Lilly and Company | 2019-07-08 |
| New Treatment of Alopecia Areata (NCT05594316) | Al-Azhar University | 2019-05-01 |
| Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata (NCT03898479) | Sun Pharmaceutical Industries, Inc. | 2019-04-04 |
| Efficacy and Tolerability Study of Two Dose Regimens of CTP-543 in Adults With Alopecia Areata (NCT03811912) | Concert Pharmaceuticals | 2019-03-21 |
| ATI-502 Topical Solution for the Treatment of Alopecia Areata (AA), Alopecia Universalis (AU) and Alopecia Totalis (AT) (NCT03759340) | Aclaris Therapeutics, Inc. | 2019-01-15 |
| Effectiveness and Safety of Tofacitinib in Patients With Extensive and Recalcitrant Alopecia Areata (NCT03800979) | Institute of Dermatology, Thailand | 2019-01-12 |
| Combined CO2 Fractional Laser With Bimatoprost 0.03% Treatment of Alopecia Areata (NCT05600673) | Ahmed Hassan Nouh MD | 2019-01-01 |
| Superficial Cryotherapy Versus Microneedling in Alopecia Areata (NCT04680234) | Sohag University | 2019-01-01 |
| A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC (NCT03661866) | Target PharmaSolutions, Inc. | 2018-12-21 |
| PF-06651600 for the Treatment of Alopecia Areata (NCT03732807) | Pfizer | 2018-12-03 |
| Cryotherapy Versus Steroids In Alopecia Areata:Trichoscopic Evaluation (NCT03473600) | Assiut University | 2018-11-01 |
| Pain Outcomes Following Intralesional Corticosteroid Injections (NCT03630198) | Vanderbilt University Medical Center | 2018-10-01 |
| A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata (NCT03570749) | Eli Lilly and Company | 2018-09-24 |
| Open Label Study of ATI-50002 Topical Solution Administered to Adult Subjects With Eyebrow Loss Due to Alopecia Areata (NCT03551821) | Aclaris Therapeutics, Inc. | 2018-04-11 |
| Efficacy and Safety of LH-8 in Paediatric Alopecia Areata (NCT03240627) | Legacy Healthcare SA | 2018-02-01 |
| Treatment of Alopecia Areata (AA) With Dupilumab in Patients With and Without Atopic Dermatitis (AD) (NCT03359356) | Icahn School of Medicine at Mount Sinai | 2018-01-09 |
| A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata (NCT03354637) | Aclaris Therapeutics, Inc. | 2017-11-29 |
| Efficacy of Twice Daily Application of LEO 124249 Ointment 30 mg/g for 12 Weeks on Eyebrow Alopecia Areata. (NCT03325296) | LEO Pharma | 2017-10-30 |
| Topical Calcipotriol Versus Narrowband Ultraviolet B in Treatment of Alopecia Areata (NCT03847441) | Aswan University Hospital | 2017-10-01 |
| Study to Evaluate the Safety and Efficacy of CTP-543 in Adults With Moderate to Severe Alopecia Areata (NCT03137381) | Concert Pharmaceuticals | 2017-08-09 |
| Biocellular-Cellular Regenerative Treatment Scaring Alopecia and Alopecia Areata (NCT03078686) | Regeneris Medical | 2017-02-17 |
| Topical Tofacitinib for the Treatment of Alopecia Areata and Its Variants (NCT02812342) | Yale University | 2016-09-01 |
| Topical 5% Minoxidil and Potent Topical Corticosteroid Versus Intralesional Corticosteroid in the Treatment of Alopecia Areata (NCT03535233) | Cairo University | 2016-03-01 |
| Pilot Study of the Safety and Efficacy of Apremilast in Subjects With Moderate to Severe Alopecia Areata (NCT02684123) | Icahn School of Medicine at Mount Sinai | 2016-02-01 |
| Topical Garlic Concentrate for Alopecia Areata in Children (NCT02691117) | Elena Pope | 2016-01-10 |
| LEO 124249 Ointment in the Treatment of Alopecia Areata (NCT02561585) | LEO Pharma | 2016-01-01 |
| A Pilot Study of Tralokinumab in Subjects With Moderate to Severe Alopecia Areata (NCT02684097) | Emma Guttman | 2016-01-01 |
| TREg Activation in the Treatment of the PELADE (Alopecia Areata) (NCT02557074) | Centre Hospitalier Universitaire de Nice | 2015-12-15 |
| A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA) (NCT02553330) | Incyte Corporation | 2015-11-18 |
| A Study of Secukinumab for the Treatment of Alopecia Areata (NCT02599129) | Icahn School of Medicine at Mount Sinai | 2015-11-01 |
| Efficacy Study of a Cosmetic Lotion in the Treatment of Alopecia Areata in Males and Females (NCT02604888) | Mexis George | 2015-10-01 |
| PAI-1 Expression in Non-scarring Hair Loss (NCT02548689) | Northwestern University | 2015-07-01 |
| Study To Evaluate The Efficacy Of Tofacitinib In Moderate To Severe Alopecia Areata, Totalis And Universalis (NCT02299297) | Columbia University | 2015-01-01 |
| Tofacitinib for the Treatment of Alopecia Areata and Its Variants (NCT02312882) | Stanford University | 2014-12-01 |
| Comparison of Topical Latanoprost vs Topical Corticosteroid in Treatment of Localized Alopecia Areata (NCT02350023) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2014-09-01 |
| The Efficiency Of The Methotrexate At Patients Affected By Grave Pelade (NCT02037191) | University Hospital, Rouen | 2014-02-01 |
| An Open-Label Single-Arm Clinical Trial to Evaluate The Efficacy of Abatacept in Moderate to Severe Patch Type Alopecia Areata (NCT02018042) | Columbia University | 2013-09-01 |
| Pilot Study to Evaluate the Efficacy of Ruxolitinib in Alopecia Areata (NCT01950780) | Columbia University | 2013-08-01 |
| At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions (NCT01931644) | Sanguine Biosciences | 2013-07-01 |
| Excimer Light for Alopecia Areata (NCT01802177) | University of British Columbia | 2013-02-01 |
| Evaluation of the Efficacy and Tolerability of Treatment With Interleukin-2 in Severe and Resistant Alopecia Areata (NCT01840046) | Centre Hospitalier Universitaire de Nice | 2012-11-01 |
| Childhood Alopecia Areata Study Using the 308-nm Excimer Laser (NCT01736007) | Phoenix Children's Hospital | 2012-08-01 |
| Stem Cell Educator Therapy in Alopecia Areata (NCT01673789) | Throne Biotechnologies Inc. | 2012-08-01 |
| Intralesional Steroids in the Treatment of Alopecia Areata (NCT01898806) | Columbia University | 2011-09-01 |
| Vytorin in the Treatment of Alopecia Areata (NCT01520077) | University of Miami | 2011-07-01 |
| The Efficacy and Safety of Different Concentrations of Localized Injections of Steroids in the Treatment of Alopecia Areata (NCT01246284) | University of British Columbia | 2010-12-01 |
| Safety and Efficacy of Bimatoprost Solution in Treating Eyelash Loss or Hypotrichosis in Children (NCT01023841) | Allergan | 2010-06-01 |
| Comparative Study Examining the Effectiveness in Use of a DERMOJET and a Normal Syringe Treatment for Patients With Hair Loss - Alopecia Areata (NCT01017510) | Sheba Medical Center | 2009-11-01 |
| Efficacy of Hair Transplantation Compared With Hypodermic Needle Irritation in Alopecia Areata (NCT01385839) | Icahn School of Medicine at Mount Sinai | 2009-10-01 |
| A Study of Vitamin D in Subjects With Alopecia Areata (NCT01328678) | Avera McKennan Hospital & University Health Center | 2009-08-01 |
| Combined Restylane and Triamcinolone Acetonide Injections for the Treatment of Alopecia Areata (NCT01797432) | University of Minnesota | 2009-03-01 |
| Treatment of Alopecia Areata of the Scalp With Intradermal Injections of Botulinum Toxin (NCT00408798) | University of British Columbia | 2007-10-01 |
| Alefacept in Patients With Severe Scalp Alopecia Areata (NCT00167102) | University of Minnesota | 2005-07-01 |
| Efficacy Study of Latanoprost and Bimatoprost Solutions in Promoting Eyelash Growth in Patients With Alopecia Areata (NCT00187577) | University of California, San Francisco | 2005-06-01 |
| Phase II Randomized Bilateral Comparison of Topical Targretin Gel 1% in Alopecia Areata (NCT00063076) | M.D. Anderson Cancer Center | 2003-05-01 |
| A Trial of Clobetasol Propionate Versus Hydrocortisone in Children With Alopecia Areata (NCT01453686) | The Hospital for Sick Children | 2002-08-01 |
| Plaquenil for Alopecia Areata, Alopecia Totalis (NCT00176982) | Hordinsky, Maria K., MD | 2002-04-01 |
| Alopecia Areata Registry (NCT00069589) | M.D. Anderson Cancer Center | 2001-11-01 |
| Characteristics of T Cells From Alopecia Areata Scalp Skin Before and After Treatment With Aldara 5% (NCT00176943) | Hordinsky, Maria K., MD | 2000-10-01 |
| Aldara for the Treatment of Extensive Alopecia Areata (NCT00177021) | Hordinsky, Maria K., MD | 2000-10-01 |
| Response of Topical Capsaicin in Alopecia Areata (NCT00176969) | University of Minnesota | 1997-08-01 |
| Pre-approval Single-patient Expanded Access for Ritlecitinib (PF-06651600) (NCT05522556) | Pfizer | |